Skip to main content

Closed

ADMA: ADMA Biologics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Operating margin40.6%

ROIC27.8%

Financially safe

Strong

Debt / equity0.52×

Interest coverage28.6×

Current ratio6.95×

Valuation

Unrated

P/E ratio12.8×

ADMA Biologics, Inc.

ADMANASDAQ Global Market·USD·Closed

ADMA Biologics, Inc.

ADMANASDAQ·USD·Closed

$8.46

−2.42%

$8.46

−$0.21 (2.42%)

52W Range

9thpctl

Volume

0.37×avg

Mkt Cap

1.96BUSD

P/E

12.8TTM

Div Yield

–ann

52W Range

9thpctl

Volume

0.37×avg

Market Cap

1.96BUSD

P/E Ratio

12.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings